State of Alaska Department of Revenue’s Royalty Pharma RPRX Stock Holding History

State of Alaska Department of Revenue’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-63,161	Closed	-$1.61M	–	1592
2024 Q4	$1.61M	Hold	63,161	–	–	0.02%	811
2024 Q3	$1.79M	Hold	63,161	–	–	0.02%	773
2024 Q2	$1.67M	Hold	63,161	–	–	0.02%	745
2024 Q1	$1.92M	Hold	63,161	–	–	0.02%	715
2023 Q4	$1.77M	Hold	63,161	–	–	0.02%	734
2023 Q3	$1.71M	Hold	63,161	–	–	0.02%	693
2023 Q2	$1.94M	Hold	63,161	–	–	0.02%	664
2023 Q1	$2.27M	Hold	63,161	–	–	0.03%	598
2022 Q4	$2.5M	Buy	63,161 +58,451	+1,241%	+$2.44M	0.03%	552
2022 Q3	$189K	Buy	+4,710	New	+$201K	﹤0.01%	1591
2021 Q1	–	Sell	-3,088	Closed	-$154K	–	1676
2020 Q4	$154K	Buy	+3,088	New	+$131K	﹤0.01%	1607

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State of Alaska Department of Revenue's RPRX Position: Q1 2025 in Review

State of Alaska Department of Revenue sold out of Royalty Pharma (RPRX) in Q1 2025, closing a stake of 63,161 shares — an estimated $1.61M sold.

State of Alaska Department of Revenue first reported a position in RPRX in Q4 2020 and held it in 11 quarters. The position peaked at $2.5M in Q4 2022. 447 funds tracked by Wall St. Rank hold RPRX as of Q1 2025.

State of Alaska Department of Revenue reported no remaining Royalty Pharma position as of Q1 2025 after selling out during the quarter.
State of Alaska Department of Revenue sold 63,161 Royalty Pharma shares in Q1 2025, an estimated $1.61M.
State of Alaska Department of Revenue first reported a position in Royalty Pharma in Q4 2020 and held it in 11 quarters.
State of Alaska Department of Revenue's Royalty Pharma position peaked at $2.5M in Q4 2022.
447 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2025.

Based on State of Alaska Department of Revenue's 13F filing for Q1 2025, filed 21 Apr 2025.